ANTIBODY COMPOSITION SPECIFICALLY BINDING TO GANGLIOSIDE GD3

摘要

It is intended to provide a composition comprising a genetically modified antibody molecule which specifically binds to ganglioside GD3 and has an N-glycoside-binding complex sugar chain in its Fc domain, wherein the N-glycoside-binding complex sugar chain is a sugar chain having no fucose attached to N-acetylglucosamine at the reducing end of the sugar chain; a transformant producing this antibody composition; a process for producing the antibody composition; and a drug containing the antibody composition.